KORU Medical Systems Stock

KORU Medical Systems EBIT

The EBIT of KORU Medical Systems (KRMD) as of Aug 6, 2026 is -2.97 M USD. In the previous year, EBIT was -6.45 M USD — a change of -53.89% (higher).

EBIT

-2.97 MUSD

YoY

-53.89%

Last updated:

In 2026, KORU Medical Systems's EBIT was -2.97 M USD, a -53.89% increase from the -6.45 M USD EBIT recorded in the previous year.

The KORU Medical Systems EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2021
-7.03 base
Jan 1, 2022
-10.78 base
Jan 1, 2023
-10.27 base
Jan 1, 2024
-6.45 base
Jan 1, 2025
-2.97 base
Jan 1, 2026 (e)
-12.08 base
Jan 1, 2027 (e)
-14.12 base
Jan 1, 2028 (e)
-15.97 base
YEAREBIT (M USD)
2028 est -15.97
2027 est -14.12
2026 est -12.08
2025 -2.97
2024 -6.45
2023 -10.27
2022 -10.78
2021 -7.03
2020 -1.25
2019 0.59
2018 1.16
2017 1.48
2016 -0.74
2015 1.18
2014 1.15
2013 1.01
2012 1.06
2011 1.29
2010 1.19
2009 0.72
2008 0.78
2007 0.19
2006 -0.02
Access this data via the Eulerpool API

KORU Medical Systems Revenue

KORU Medical Systems Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
23.49 M USD
-7.03 M USD
-4.56 M USD
Jan 1, 2022
27.90 M USD
-10.78 M USD
-8.66 M USD
Jan 1, 2023
28.52 M USD
-10.27 M USD
-13.74 M USD
Jan 1, 2024
33.65 M USD
-6.45 M USD
-6.07 M USD
Jan 1, 2025
41.13 M USD
-2.97 M USD
-2.64 M USD
Jan 1, 2026 (e)
48.69 M USD
-12.08 M USD
-2.03 M USD
Jan 1, 2027 (e)
56.94 M USD
-14.12 M USD
1.48 M USD
Jan 1, 2028 (e)
64.40 M USD
-15.97 M USD
4.62 M USD

KORU Medical Systems Margins

KORU Medical Systems stock margins

The KORU Medical Systems margin analysis displays the gross margin, EBIT margin, as well as the profit margin of KORU Medical Systems. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for KORU Medical Systems.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
58.62 %
-29.93 %
-19.42 %
Jan 1, 2022
55.09 %
-38.65 %
-31.05 %
Jan 1, 2023
58.59 %
-36.01 %
-48.18 %
Jan 1, 2024
63.40 %
-19.16 %
-18.03 %
Jan 1, 2025
62.26 %
-7.23 %
-6.41 %
Jan 1, 2026 (e)
62.26 %
-24.80 %
-4.17 %
Jan 1, 2027 (e)
62.26 %
-24.80 %
2.60 %
Jan 1, 2028 (e)
62.26 %
-24.80 %
7.17 %

KORU Medical Systems Stock analysis

What does KORU Medical Systems do? Repro Med Systems Inc is a US-based company specializing in the development and manufacturing of medical devices for infusion therapy. The company was founded in 1980 by Edward L. Swanson and is headquartered in Chester, New York. Repro Med Systems Inc started as a small family business developing medical devices for reproductive medicine. Over the years, the company expanded and began focusing on other medical applications. In the 1990s, the company developed an innovative infusion pump system, later known as the "Freedom Syringe Infusion System." This system received numerous patents and proved to be a groundbreaking innovation in infusion therapy. Repro Med Systems Inc specializes in selling medical devices for infusion therapy. The company uses a direct sales model, allowing them to sell products directly to end customers. This enables the company to better understand customer needs and quickly respond to industry changes. Repro Med Systems Inc offers a variety of products for infusion therapy, including the "Freedom Syringe Infusion System," the "MRidium" infusion pump system, and the "Freo" intermittent dosing infusion pump system. The "Freedom Syringe Infusion System" is a portable infusion pump system that allows the administration of medications and fluids through a needleless disposable syringe. The system is easier to use than conventional infusion pumps and provides patients with more freedom and mobility during treatment. The "MRidium" infusion pump system has been specifically designed for use in magnetic resonance imaging (MRI). The system is immune to magnetic interference and can be used during an MRI examination to provide patients with infusions. The "Freo" intermittent dosing infusion pump system is a simple and reliable system that allows the administration of medications in variable doses. The system is ideal for pain management and enables patients to administer their medications quickly and easily. In conclusion, Repro Med Systems Inc is an innovative company specializing in the development and manufacturing of medical devices for infusion therapy. The company has experienced remarkable growth in recent years and is now a key player in the industry. With its focus on innovation and customer satisfaction, the company is expected to continue to be successful in the future. KORU Medical Systems is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing KORU Medical Systems's EBIT

KORU Medical Systems's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of KORU Medical Systems's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

KORU Medical Systems's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in KORU Medical Systems’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about KORU Medical Systems stock

EBIT of KORU Medical Systems is -2.97 M USD in 2026.

EBIT of KORU Medical Systems changed from -6.45 M USD to -2.97 M USD, representing a -53.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT KORU Medical Systems since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's KORU Medical Systems historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — KORU Medical Systems

All Key Metrics — KORU Medical Systems